Annually on December 1st, we commemorate World AIDS Day and reflect upon our worldwide response to the HIV/AIDS epidemic. This year has been especially poignant as we mark 40 years since the first five cases of what later became known as AIDS were officially reported and honor the more than 36 million people, including 700,000 in the United States, who have died from AIDS-related illness globally since the start of the epidemic. The U.S. Government’s theme for World AIDS Day 2021—Ending the HIV Epidemic: Equitable Access, Everyone’s Voice—highlights the Biden-Harris Administration’s strong commitment to ending the HIV epidemic globally by addressing health inequities and ensuring the voices of people with HIV are central in all our work. As we prioritize leading the COVID-19 response, including becoming an arsenal of vaccines for the world, and helping every country and community build back better, we must at the same time forge ahead, innovate, and invest in communities to end the HIV epidemic everywhere. This blog reflects on those we have lost to AIDS and honor sthe nearly 38 million people living with HIV, renewing the U.S. government's commitment to work with diverse stakeholder communities to end the HIV epidemic across the United States and around the world.
Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health ApproachWorld Health Organization (WHO), 2021
These consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring bring together existing and new clinical and programmatic recommendations across different ages, populations and settings, bringing together all relevant WHO guidance on HIV produced since 2016. It serves as an update to the previous edition of the consolidated guidelines on HIV. These guidelines continue to be structured along the continuum of HIV care. Information on new combination prevention approaches, HIV testing, ARV regimens and treatment monitoring are included. There is a new chapter on advanced HIV disease that integrates updated guidance on the management of important HIV comorbidities, including cryptococcal disease, histoplasmosis and tuberculosis. The chapter on general HIV care, contains a new section on palliative care and pain management, and up to date information on treatment of several neglected tropical diseases, such as visceral leishmaniasis and Buruli ulcer. New recommendations for screening and treating of cervical pre-cancer lesions in women living with HIV are also addressed in this chapter.
The goal of this document is to describe the principles of CLM, outline an approach to establishing CLM activities and explore the factors that facilitate and hinder CLM effectiveness. It should contribute to establishing in-country platforms whereby CLM can provide data principally related to HIV service provision. The framework outlined also gives structure to facilitate engagement by external partners.
Multi-Month Dispensing for Children & Adolescents Living with HIV: A Guide for Community Case Workers in OVC ProgramsPACT, 2021
This guide is meant to help community case workers or facility case managers working on an orphans and vulnerable children (OVC) program, to understand their role in supporting multi-month dispensing (MMD) of antiretroviral (ARV) medicines for children and adolescents living with HIV (CLHIV/ALHIV). The guide will explain the basics of MMD, including: What is MMD? Which children are eligible for MMD? Why is MMD beneficial for CLHIV/ALHIV? The guide will also explain what the role as a community case worker (CCW) is in supporting CLHIV/ALHIV on MMD, including how they: Know which children and adolescents are on MMD; Know which children are not on MMD but are eligible to start MMD, and what to do; Support children and adolescents on MMD and their caregivers; Ensure that CLHIV and ALHIV are adhering to optimal regimens even when they are not attending the clinic on a frequent basis; Collect and report needed information about CLHIV/ALHIV on MMD; Know when to communicate with health care providers about CLHIV/ALHIV on MMD.
Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoringWorld Health Organization (WHO), 2021
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living with HIV who are being treated for tuberculosis. WHO is currently in the process of collating all HIV normative guidance developed since 2016 in order to publish the third edition of the consolidated HIV guidelines in July 2021. This updated version will include the new clinical guidance presented here.
This set of tools (English and French) educates and encourages discussion about multi-month dispensing (MMD) of antiretroviral medications between providers, case workers, counselors, caregivers, and children and adolescents living with HIV. The job aids will help providers orient clients and caregivers to MMD and support them in identifying and addressing challenges with the treatment. The client literacy materials provide care instructions for clients and caregivers to follow at home.
As the world responds to COVID-19 and prepares for future pandemics, it would be much better served by a close examination and application of the lessons learned over the 40-year fight against HIV. The data and case studies compiled by UNAIDS within this year’s Global AIDS Update report show that great successes have been achieved against AIDS when sufficient resources are mobilized—and when the most affected communities are empowered to ensure that those resources are equitably used. By contrast, division, disparity and a disregard for human rights are among the failures that have allowed HIV to remain a global health crisis.
Four decades after the first cases of AIDS were reported, new data from UNAIDS show that dozens of countries achieved or exceed the 2020 targets set by the United Nations General Assembly in 2016—evidence that the targets were not just aspirational but achievable. COVID-19 has shown the fragility of the health and development gains made over the past decades and has exposed glaring inequalities. To get the world on track to end AIDS by 2030, the global AIDS community and UNAIDS have used an inequalities lens to develop an ambitious and achievable strategy with new targets to reach by 2025. Ending inequalities requires HIV responses that can reach the populations currently being left behind.
Due to the COVID-19 pandemic, RRHO pivots to a virtual DHIS2 training for NACP Liberia to better leverage data to strengthen HIV programsResilient & Responsive Health Organizations (RRHO), 2021
From September to October 2020, the HRSA-funded Resilient and Responsive Health Organization (RRHO) project conducted a virtual training to build the capacity of eight monitoring and evaluation (M&E) staff from the National AIDS and STI Control Program (NACP), Ministry of Health (MOH) in Liberia. To facilitate the achievement of zero new infections, zero AIDS-related deaths, and zero AIDS-related stigma and discrimination in Liberia by 2030, NACP uses District Health Information Software 2 (DHIS2). Due to the COVID-19 pandemic, the in-person training was replaced with seven virtual sessions. Led by RRHO’s DHIS2 experts, each two-hour session introduced DHIS2 concepts and building blocks, such as data elements, organization units, and form design.
The new Global AIDS Strategy (2021–2026) seeks to reduce the inequalities that drive the AIDS epidemic and put people at the centre to get the world on-track to end AIDS as a public health threat by 2030. Decades of experience and evidence from the HIV response show that intersecting inequalities are preventing progress towards ending AIDS. Drawing on key lessons learned from the intersecting HIV and COVID-19 pandemics, the Strategy leverages proven tools and approaches of the HIV response. It identifies where, why and for whom the HIV response is not working. It outlines strategic directions and priority actions to be implemented by global, regional, country and community partners by 2025 to get the HIV response on-track to end AIDS by 2030.